Human Genome Project will be finished by 2003, project leaders say.(Originated from Knight Ridder Newspapers)

From: Knight Ridder/Tribune News Service | Date: September 14, 1998| Author: McFarling, Usha Lee | Copyright information

WASHINGTON _ The Human Genome Project, a behemoth federal plan to map and read the entire length of human DNA, will be sped up and finished by 2003, two years ahead of schedule, project leaders said Monday.

The project is a race to read the so-called ``book of life,'' the detailed genetic instructions that control the workings of every cell _ and in part control who we are, how our brains and bodies work and often, why we get sick.

Already, scientists h...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Scientists Discuss Hope, Ethical Issues of Human Genome Projects.
Knight Ridder/Tribune Business News ; Knight Ridder/Tribune Business News Apr. 10 -- Scientists around the world are working to unravel the ... of the economic system not the fault of scientists. Visit Boulder News, the World Wide Web site of the Daily Camera, at http://www.bouldernews ...
Human Genome Project will be finished by 2003, project leaders say.(Originated from Knight Ridder Newspapers)
Knight Ridder/Tribune News Service ; ... their completion goal and the increased pace of government findings would speed his project as well. ``This is nothing but good news,'' he said in a telephone interview. Collins said he had discussed the plans with Venter and he planned to cooperate fully with ...
Federal pact lifts drug firm; Human Genome Sciences sells anthrax treatment.(BUSINESS)(YOUR MONEY: STOCK VIEW)
The Washington Times ; Byline: Jen Haberkorn, THE WASHINGTON TIMES Shares of Human Genome Sciences Inc. rose more than 3 percent yesterday after the Rockville drug company announced a contract to supply the federal government with medicine to treat anthrax. Human Genome will supply 10 grams of the drug, ABthrax, to the
The human genome sequence: Impact on health care
Indian Journal of Medical Research ; ... 80s work was initiated to create physical maps of genomes of the yeast, Saccharomyces ... Previously constructed genetic and physical maps were used to choose the BAC clones for ... previously determined genetic and physical maps. Techniques such as fluorescent in situ ...
Boulder, Colo., Biotechs Bet Human Genome Project Will Profit.
Knight Ridder/Tribune Business News ; Knight Ridder/Tribune Business News Oct. 31-- All human disease is genetic in origin ... databases -- some private, others public. The good news is the sequences are going much faster. The bad news is 90 percent or more of the partial gene sequences ...
Pfizer deal lifts Human Genome.(BUSINESS)(YOUR MONEY: STOCK VIEW)
The Washington Times ; ... Company shares closed on the Nasdaq Stock Market yesterday at $13.08, up 2 percent from a week earlier at $12.78. The deal follows news that Human Genome is laying off 75 workers, or 7 percent of its work force, with redundant job duties. Human Genome is hiring ...
Glaxo markets diabetes drug by Rockville, Md., biotech Human Genome Sciences.
Baltimore Sun (Baltimore, MD) ; ... the newspaper, go to http://www.baltimoresun.com. (c) 2004, The Baltimore Sun. Distributed by Knight Ridder/Tribune Business News. For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-65 ...
Human Genome Makes British Deal; Md. Firm Pushing Search for Treatments
The Washington Post ; Human Genome Sciences Inc. said yesterday that it had struck a 10- year deal with a British biotechnology company that should accelerate its push to treat disease with customized antibodies. Human Genome, a Rockville gene-hunting company with a close following on Wall Street, said it will buy a 6
FIVE WAYS TO RIDE A WAVE; Human Genome's Tests Could Tell
The Washington Post ; ... positive they would likely give the stock another big boost. Conversely, Human Genome is at such a critical stage that any bad news about these earliest drugs would likely be taken by the markets as a big negative. Start-up biotechnology companies have seen ...
Pfizer Deal Lifts Shares of Rockville, Md.-Based Human Genome Sciences.
Knight Ridder/Tribune Business News ; ... Washington Times Knight Ridder/Tribune Business News Dec. 23--Shares of Human Genome Sciences ... week earlier at $12.78. The deal follows news that Human Genome is laying off 75 workers ... Distributed by Knight Ridder/Tribune Business News. HGSI, PFE,